Please assess the completion status of the following clinical trial:

Trial Title: Nutritional Strategies for Metabolic Health in Aging

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 60-80 years of age~* Body mass index of 30-40 kg/m2~* Participants must be capable of understanding the consent process~* Participants must be capable of signing the consent form~* Participants must have access to transportation to the clinic site~Exclusion Criteria:~* Creatinine \>1.6~* Serum glutamate pyruvate transaminase \>2 times normal~* Resting blood pressure above 160/90 mmHg~* Use of Gemfibrozil~* Use of corticosteroids~* Previously diagnosed diabetes (fasting blood glucose ≥ 126 mg/dl)~* History of kidney or liver disease~* Heart disease as indicated by interventional procedures~* Recent history of alcoholism~* Physical or neurological disorder that would prevent them from completing the functional tests~* Lactose intolerance~* Active cancer within the last two years~* Chronic inflammatory conditions that preclude completion of functional tests

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- Experimental Meal Replacement (Type: EXPERIMENTAL): Participants randomized to this arm will consume 5 servings/day of experimental meal replacement in conjunction of 400 kcal of solid food for 12 weeks during the weight loss portion of the trial. This will be followed by the consumption of 1 serving/day of experimental meal replacement for 12 weeks during the weight maintenance portion of the trial.
- Bariatrics Advantage Meal Replacement (Type: ACTIVE_COMPARATOR): Participants randomized to this arm will consume 5 servings/day of Bariatrics Advantage meal replacement in conjunction of 400 kcal of solid food for 12 weeks during the weight loss portion of the trial. This will be followed by the consumption of 1 serving/day of Bariatrics Advantage meal replacement for 12 weeks during the weight maintenance portion of the trial.

Based on this trial design, predict the completion outcome and termination type (if applicable).